Our Grangemouth, UK facility is USFDA, MHRA & PMDA Japan inspected, offering development, clinical & commercial scale manufacture of bio-conjugates including Antibody Drug Conjugates (ADCs) since 2004. The site provides full process & analytical development services to support proof-of-concept & Toxicology studies with commercial manufacture of ADCs since 2012.